Albemarle (ALB) Misses Q3 EPS by $1.11, Beats on Revenue
Tweet
Share
E-mail
Get Alerts ALB Hot Sheet
Price: $128.34 --0%
Financial Fact:
Cost of goods sold: 415.04M
Today's EPS Names:
VAXX, NMRD, EGRX, More
Financial Fact:
Cost of goods sold: 415.04M
Today's EPS Names:
VAXX, NMRD, EGRX, More
Join SI Premium – FREE
Albemarle (NYSE: ALB) reported Q3 EPS of ($1.55), $1.11 worse than the analyst estimate of ($0.44). Revenue for the quarter came in at $1.4 billion versus the consensus estimate of $1.37 billion.
For earnings history and earnings-related data on Albemarle (ALB) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Karyopharm Therapeutics (KPTI) Misses Q2 EPS by $1.01, Beats on Revenue; Offers FY26 Revenue Guidance
- ADC Therapeutics SA (ADCT) Tops Q2 EPS by 11c
- Bragg Gaming Group Inc. (BRAG) Tops Q2 EPS by 2c
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
